Ratjen, Felix

A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation

Ramsey, B. W., Davies, J., McElvaney, N. G., Tullis, E., Bell, S. C., Dřevínek, P., Griese, M., McKone, E. F., Wainwright, C. E., Konstan, M. W., et al. (2011) · New England Journal of Medicine

Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery

Cited by 2,195

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR

Wainwright, C. E., Elborn, J. S., Ramsey, B. W., Marigowda, G., Huang, X., Cipolli, M., Colombo, C., Davies, J. C., De Boeck, K., Flume, P. A., et al. (2015) · New England Journal of Medicine

Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery

Cited by 1,622

ECFS best practice guidelines: the 2018 revision

Castellani, C., Duff, A. J. A., Bell, S. C., Heijerman, H. G. M., Munck, A., Ratjen, F., Sermet-Gaudelus, I., Southern, K. W., Barben, J., Flume, P. A., et al. (2018) · Journal of Cystic Fibrosis

Cystic Fibrosis Research AdvancesNeonatal Respiratory Health Research

Cited by 765

European cystic fibrosis society standards of care: best practice guidelines

Smyth, A. R., Bell, S. C., Bojcin, S., Bryon, M., Duff, A., Flume, P., Kashirskaya, N., Munck, A., Ratjen, F., Schwarzenberg, S. J., et al. (2014) · Journal of Cystic Fibrosis

Cystic Fibrosis Research AdvancesNeonatal Respiratory Health Research

Cited by 582

Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis

Waters, V., Stanojevic, S., Atenafu, E. G., Lu, A., Yau, Y., Tullis, E., & Ratjen, F. (2012) · European Respiratory Journal

Cystic Fibrosis Research AdvancesChronic Obstructive Pulmonary Disease (COPD) Research

Cited by 256

Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)

McKone, E. F., Borowitz, D., Drevinek, P., Griese, M., Konstan, M. W., Wainwright, C., Ratjen, F., Sermet-Gaudelus, I., Plant, B., Munck, A., et al. (2014) · The Lancet Respiratory Medicine

Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery

Cited by 211

Influence of Interleukin‐10 on Aspergillus fumigatus Infection in Patients with Cystic Fibrosis

Brouard, J., Knauer, N., Boelle, P., Corvol, H., Henrion‐Caude, A., Flamant, C., Bremont, F., Delaisi, B., Duhamel, J., Marguet, C., et al. (2005) · The Journal of Infectious Diseases

Cystic Fibrosis Research AdvancesAntifungal resistance and susceptibility

Cited by 120

Exhaled nitric oxide in children after accidental exposure to chlorine gas

Grasemann, H., Tschiedel, E., Groch, M., Klepper, J., & Ratjen, F. (2007) · Inhalation Toxicology

Asthma and respiratory diseasesOccupational exposure and asthma

Cited by 11

Pulmonary artery hypertension: an underrated disease manifestation in cystic fibrosis?

Ratjen, F. (2016) · The Lancet Respiratory Medicine

Pulmonary Hypertension Research and TreatmentsCystic Fibrosis Research Advances

Cited by 9